A Study to Evaluate Glofitamab Monotherapy and Glofitamab + Chemoimmunotherapy in Pediatric and Young Adult Participants With Relapsed/Refractory Mature B-Cell Non-Hodgkin Lymphoma
Summary
- Eligibility
- for people ages 6 months to 30 years (full criteria)
- Location
- at Oakland 5378538, California 5332921 and other locations
- Dates
- study startedstudy ends around
- Principal Investigator
- by Jennifer Michlitsch
Description
Summary
Official Title
Keywords
Eligibility
Locations
Lead Scientist at UCSF
- Jennifer Michlitsch
Professor, Pediatrics, School of Medicine. Authored (or co-authored) 23 research publications
Details
- Status
- accepting new patients
- Start Date
- Completion Date
- (estimated)
- Sponsor
- Hoffmann-La Roche
- ID
- NCT05533775
- Phase
- Phase 1/2 research study
- Study Type
- Interventional
- Participants
- Expecting 65 study participants
- Last Updated